Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.3200
-0.0123 (-3.70%)
At close: May 19, 2026, 4:00 PM EDT
0.3301
+0.0101 (3.16%)
After-hours: May 19, 2026, 7:38 PM EDT

Jupiter Neurosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1235354---
Market Cap Growth
-43.62%-90.08%----
Enterprise Value
14.0840.43354.38000
Last Close Price
0.321.0210.70---
PS Ratio
287.041612.01----
PB Ratio
--19.1884.90---
P/TBV Ratio
-4.17-19.2873.82---
EV/Sales Ratio
348.111855.09----
Debt / Equity Ratio
-1.73-2.890.04-0.38-0.26-0.18
Net Debt / Equity Ratio
-1.74-2.900.05-0.38-0.26-0.13
Net Debt / EBITDA Ratio
-0.74-0.60-0.07-0.57-0.53-0.17
Net Debt / FCF Ratio
-1.41-0.98-0.06-4.62-1.47-0.38
Asset Turnover
-0.00000.520
Inventory Turnover
-0.05----
Quick Ratio
-0.0000.000.010.06
Current Ratio
0.020.040.060.000.010.08
Return on Equity (ROE)
276.00%-738.83%299.46%73.91%80.47%107.64%
Return on Assets (ROA)
-137.19%-151.43%-97.35%-2013.22%-759.96%-635.93%
Return on Invested Capital (ROIC)
-175.48%-226.17%-267.20%115.97%75.39%93.09%
Return on Capital Employed (ROCE)
282.75%-754.53%432.33%61.21%57.03%88.74%
Buyback Yield / Dilution
-15.57%-20.31%-9.01%-0.13%-7.56%-4.25%
Total Shareholder Return
-15.57%-20.31%-9.01%-0.13%-7.56%-4.25%
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q